weixin Jia

Dr. weixin Jia

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Virologica Sinica
Verified
Journal Article
Closed access
PDF file
YWYifan Wu
Yifan Wu
JHJingkai Hu
Jingkai Hu
XJXuanjiang Jin
Xuanjiang Jin
XLXiao Li
Xiao Li
JWJinfeng Wang
Jinfeng Wang
WJweixin Jia
weixin Jia

1 August 2020 in Emerging Infectious Diseases
Verified
Journal Article
Open access
JZJiahao Zhang
Jiahao Zhang
HYHejia Ye
Hejia Ye
Huanan LiHuanan Li
Huanan Li
KMKaixiong Ma
Kaixiong Ma
WQWeihong Qiu
Weihong Qiu
Wenbao QiWenbao Qi
Wenbao Qi
Evolution of Influenza A(H7N9) Viruses

18 August 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
HLHuanan Li
Huanan Li
QLQian Li
Qian Li
BLBo Li
Bo Li
YGYang Guo
Yang Guo
JXJinchao Xing
Jinchao Xing
MLMing Liao
Ming Liao
Since it firstly emerged in China in 2013, clade 2.3.4.4 H5N6 highly pathogenic avian influenza viruses (HPAIVs) has rapidly replaced predominant H5N1 to become the dominant H5 subtype in China, especially in ducks. Not only endemic in China, it also crossed the geographical barrier and emerged in South Korea, Japan, and Europe. Here, we analyzed the genetic properties of the clade 2.3.4.4 H5N6 HPAIVs with full genome sequences available online together with our own isolates. Phylogenetic analysis showed that clade 2.3.4.4 H5N6 HPAIVs continuously reassorted with local H5, H6, and H7N9/H9N2. Species analysis reveals that aquatic poultry and migratory birds became the dominant hosts of H5N6. Adaption to aquatic poultry might help clade 2.3.4.4 H5N6 better adapt to migratory birds, thus enabling it to become endemic in China. Besides, migratory birds might help clade 2.3.4.4 H5N6 transmit all over the world. Clade 2.3.4.4 H5N6 HPAIVs also showed a preference for α2,6-SA receptors when compared to other avian origin influenza viruses. Experiments in vitro and in vivo revealed that clade 2.3.4.4 H5N6 HPAIVs exhibited high replication efficiency in both avian and mammal cells, and it also showed high pathogenicity in both mice and chickens, demonstrating high risk to public health. Considering all the factors together, adaption to aquatic poultry and migratory birds helps clade 2.3.4.4 H5N6 overcome the geographical isolation, and it has potential to be the next influenza pandemic in the world, making it worthy of our attention.

1 August 2022 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
JCJunhong Chen
Junhong Chen
LXLingyu Xu
Lingyu Xu
TLTengfei Liu
Tengfei Liu
SXShumin Xie
Shumin Xie
KLKe Li
Ke Li
WJweixin Jia
weixin Jia
Reassortant Avian Influenza A(H5N6) Virus, China

3 March 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JWJinfeng Wang
Jinfeng Wang
XJXuanjiang Jin
Xuanjiang Jin
JHJingkai Hu
Jingkai Hu
YWYifan Wu
Yifan Wu
MZMengmeng Zhang
Mengmeng Zhang
WJweixin Jia
weixin Jia
This study aimed to investigate the genetic evolution of the H9N2 avian influenza virus (AIV). Whole genome phylogenetic trees were constructed based on 306 H9N2 avian influenza strains collected in China from 2014 to 2019. The results showed that eight gene sequences were clustered separately according to their dominant clades, and a total of 10 genotypes were identified (seven of which were novel types). Among them, G57 genotype was confirmed as the most prevalent genotype with a frequency of 94%. In China, the G57 genotype of H9N2 first emerged in 2007, and then became the most common genotype in 2013. Therefore, the nucleotide substitution rates of G57 genotype in HA and NA genes collected from 2007 to 2019 were estimated, and the positive selection pressure sites in the same data set were measured. Taking 2013 as the boundary, the time period was divided into two periods: 2007–2012 and 2013–2019. From 2007 to 2012, multiple genotypes coexisted and could bear the pressures from both nature and environment; while G57 genotype was still in the adaptation stage, subjected to less selection pressure and in the process of slow evolution. However, from 2013 to 2019, G57 became the dominant genotype, and most of the external pressure reacted on it. Moreover, G57 genotype showed better adaptability than other genotypes. From 2013 to 2019, the nucleotide substitution rates of the HA gene were increased, and the positive selection pressures on HA and NA genes were stronger compared to those from 2007 to 2012. To sum up, the absolutely dominant G57 genotype exhibited a relatively constant genotype frequency and experienced adaptive evolution and natural selection simultaneously during the monitoring period. Therefore, urgent attention and diligent surveillance of H9N2 avian influenza virus are becoming increasingly important.

24 November 2021 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
JCJunhong Chen
Junhong Chen
ZLZhaojie Liu
Zhaojie Liu
KLKe Li
Ke Li
XLXiao Li
Xiao Li
LXLingyu Xu
Lingyu Xu
WJweixin Jia
weixin Jia
In early 2021, roughly six months after the H7N9 H7-Re3 and H7N9 rLN79 vaccine strains were introduced into China, we monitored a number of H7N9 subtype avian influenza viruses, which could have escaped vaccine-induced immunity in live poultry markets (LPMs) in Yunnan, Hebei, Shanxi, and Guangdong provinces, China. To investigate whether these viruses were a novel H7N9 variant of highly pathogenic avian influenza (HPAI) virus and whether they had the potential for further spread, we characterized the genetic evolution, antigenic divergence, and pathogenicity of the viruses in the context of vaccine immunity. The results show further diversification in the HA gene of newly isolated HPAI H7N9 viruses compared with antigenic variants that emerged after the period of 2017–2019. There were clear antigenic differences between current vaccines and these viruses, and SPF broilers under vaccine protection could not resist virus challenges. Our study demonstrates that the current vaccine has insufficient protective capacity against the novel H7N9 variants under experimental conditions. A novel H7N9 immune escape virus has emerged. Faced with potential outbreaks, we should strengthen surveillance and update vaccine strains. This article is protected by copyright. All rights reserved